Total planned funding: $90,822,823
Allocations
Countries/Regions
| Asia Regional Program | $90,822,823 |
Organizational Types
| NGO | $30,726,299 |
| Own Agency | $25,010,796 |
| University | $10,629,615 |
| Unknown | $9,329,667 |
| Multi-lateral Agency | $5,560,608 |
| Host Country Government Agency | $5,309,278 |
| Private Contractor | $4,010,112 |
| Other USG Agency | $246,448 |
| Implementing Agency | $0 |
Program Areas
| Treatment | $23,586,827 |
| Governance and Systems | $21,799,613 |
| Management and Operations | $14,868,329 |
| Prevention | $12,474,440 |
| Testing | $10,906,895 |
| Care | $7,186,719 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $23,299,289 |
| HVMS: Management and Operations | $14,868,329 |
| OHSS: Health Systems Strengthening | $11,056,353 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $10,907,012 |
| HVCT: Testing: HIV Testing and Counseling | $10,906,895 |
| HVSI: Strategic Information | $7,847,890 |
| HBHC: Care: Adult Care and Support | $5,429,376 |
| HLAB: Laboratory Infrastructure | $2,895,370 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,432,591 |
| HKID: Care: Orphans and Vulnerable Children | $1,244,726 |
| PDCS: Care: Pediatric Care and Support | $300,476 |
| HVTB: Care: TB/HIV | $212,141 |
| HTXD: Treatment: ARV Drugs | $175,500 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $116,000 |
| PDTX: Treatment: Pediatric Treatment | $112,038 |
| HMBL: Biomedical Prevention: Blood Safety | $18,837 |
Top Partner Programs
U.S. Centers for Disease Control and Prevention:
$11,437,999
Countries/Regions
Asia Regional Program
| 2020 | $11,437,999 |
U.S. Agency for International Development:
$5,580,199
Countries/Regions
Asia Regional Program
| 2020 | $5,580,199 |